265 related articles for article (PubMed ID: 16418275)
1. Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties.
Tricarico D; Mele A; Lundquist AL; Desai RR; George AL; Conte Camerino D
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1118-23. PubMed ID: 16418275
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
Chan KW; Wheeler A; Csanády L
J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
[TBL] [Abstract][Full Text] [Related]
3. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
4. C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.
Matsuoka T; Matsushita K; Katayama Y; Fujita A; Inageda K; Tanemoto M; Inanobe A; Yamashita S; Matsuzawa Y; Kurachi Y
Circ Res; 2000 Nov; 87(10):873-80. PubMed ID: 11073882
[TBL] [Abstract][Full Text] [Related]
5. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.
Sunaga Y; Gonoi T; Shibasaki T; Ichikawa K; Kusama H; Yano H; Seino S
Eur J Pharmacol; 2001 Nov; 431(1):119-25. PubMed ID: 11716850
[TBL] [Abstract][Full Text] [Related]
6. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain.
Chen M; Dong Y; Simard JM
J Neurosci; 2003 Sep; 23(24):8568-77. PubMed ID: 13679426
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats.
Tricarico D; Mele A; Liss B; Ashcroft FM; Lundquist AL; Desai RR; George AL; Conte Camerino D
Neuromuscul Disord; 2008 Jan; 18(1):74-80. PubMed ID: 17825556
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the trafficking efficiency and functional properties of ATP-sensitive potassium channels through a single amino acid in the sulfonylurea receptor.
Cartier EA; Shen S; Shyng SL
J Biol Chem; 2003 Feb; 278(9):7081-90. PubMed ID: 12496311
[TBL] [Abstract][Full Text] [Related]
10. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
[TBL] [Abstract][Full Text] [Related]
12. Dual response of the KATP channels to staurosporine: a novel role of SUR2B, SUR1 and Kir6.2 subunits in the regulation of the atrophy in different skeletal muscle phenotypes.
Mele A; Camerino GM; Calzolaro S; Cannone M; Conte D; Tricarico D
Biochem Pharmacol; 2014 Sep; 91(2):266-75. PubMed ID: 24998494
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis and characteristics of KATP channel in human corporal smooth muscle cells.
Insuk SO; Chae MR; Choi JW; Yang DK; Sim JH; Lee SW
Int J Impot Res; 2003 Aug; 15(4):258-66. PubMed ID: 12934053
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor.
Reimann F; Tucker SJ; Proks P; Ashcroft FM
J Physiol; 1999 Jul; 518 ( Pt 2)(Pt 2):325-36. PubMed ID: 10381582
[TBL] [Abstract][Full Text] [Related]
15. MCC-134, a novel vascular relaxing agent, is an inverse agonist for the pancreatic-type ATP-sensitive K(+) channel.
Shindo T; Katayama Y; Horio Y; Kurachi Y
J Pharmacol Exp Ther; 2000 Jan; 292(1):131-5. PubMed ID: 10604939
[TBL] [Abstract][Full Text] [Related]
16. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
[TBL] [Abstract][Full Text] [Related]
17. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of aortic KIR6.1 and SUR2B in hypertension does not correlate with changes in the functional role of K(ATP) channels.
Blanco-Rivero J; Gamallo C; Aras-López R; Cobeño L; Cogolludo A; Pérez-Vizcaino F; Ferrer M; Balfagon G
Eur J Pharmacol; 2008 Jun; 587(1-3):204-8. PubMed ID: 18471810
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cells.
Gopalakrishnan M; Molinari EJ; Shieh CC; Monteggia LM; Roch JM; Whiteaker KL; Scott VE; Sullivan JP; Brioni JD
Br J Pharmacol; 2000 Apr; 129(7):1323-32. PubMed ID: 10742287
[TBL] [Abstract][Full Text] [Related]
20. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]